Japan - the nation with the most rapidly increasing ageing population, is facing a similar challenge to UK: how to sustainably provide vital health services to their ageing population while containing ever-growing health expenditures.
Japan’s ageing trend is expected to continue until 2042. The future healthcare system requires a paradigm shift and policy support that would allow Japan to ensure that the Japanese people can keep enjoying longer, healthier, and productive lives, even with dementia.
Key public policy areas of focus have been identified, such as: expanding models of care to enable older adults to remain at home as they age; creating age friendly design; adopting remote care technology to facilitate more coordinated and more efficient care; and promoting a more active and mobile 21st century society with age-friendly urban design.
In 2016 and 2017, the Japanese Government, via Japan Agency for Medical Research and Development (AMED), has commissioned the Health and Global Policy Institute (HGPI), an independent health policy think tank, to develop a policy proposal for modeling Public Private Partnerships (PPP) focused on dementia research, in the aim of identifying the best possible PPP models for Japan.
HGPI proposed the best possible way to establish PPP, with a concrete framework in Japan, by utilizing not only public funds but also with private funds to promote dementia research effectively and efficiently, while looking over the diversity and complexity of the needs for dementia research and possibility of international collaboration. Consequently, putting such models into practice in the rest of Asia and the world.
On May 14, 2019, as a part of the International Masterclass on Dementia Care, Design and Ageing by DSDC, University of Stirling, Ryoji NORITAKE, CEO and Board Member of HGPI, will present the current trends and challenges of Japan’s health policy around dementia. Then he will discuss with you about public and private partnership for dementia research in Japan.
Looking forward to the UK-Japan dialogue!
~ Ryoji NORITAKE, CEO, Health & Global Policy Institute, Japan